Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion

Hiroko Nagao-Kitamoto1, Takao Setoguchi2, Sho Kitamoto3

  • 1Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Cancer Letters
|December 3, 2014
PubMed

Insights

GLI2 signaling upregulates ribosomal protein S3 (RPS3) expression, promoting osteosarcoma cell migration and invasion. Targeting this GLI2-RPS3 pathway may offer new therapeutic strategies for invasive osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • GLI2 is implicated in the proliferation, migration, and invasion of mesenchymal stem cells and osteosarcoma cells.
  • Understanding the molecular mechanisms of GLI2-driven osteosarcoma metastasis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms by which GLI2 mediates osteosarcoma metastasis.
  • To identify downstream targets of GLI2 involved in osteosarcoma cell invasion and migration.

Main Methods:

  • Microarray analysis was employed to identify GLI2 target genes.
  • Real-time PCR and siRNA were used to assess gene expression and functional roles.
  • Immunohistochemical analysis was performed on osteosarcoma tissue samples.

Main Results:

  • Ribosomal protein S3 (RPS3) was identified as a direct GLI2 target gene.
  • GLI2 positively regulates RPS3 expression, which in turn enhances osteosarcoma cell migration and invasion.
  • RPS3 expression levels correlated with osteosarcoma metastasis in patient samples.

Conclusions:

  • The GLI2-RPS3 signaling axis plays a significant role in promoting osteosarcoma cell invasion and metastasis.
  • GLI2-RPS3 signaling represents a potential biomarker for invasive osteosarcoma and a promising therapeutic target.